Prudential plc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.5M | Sell |
256,041
-89,663
| -26% | -$5.23M | 0.09% | 142 |
|
|
2025
Q4 | $18.6M | Sell |
345,704
-117,602
| -25% | -$5.66M | 0.15% | 104 |
|
|
2025
Q3 | $20.9M | Buy |
463,306
+36,159
| +8% | +$1.69M | 0.15% | 89 |
|
|
2025
Q2 | $19.8M | Buy |
427,147
+137,399
| +47% | +$6.74M | 0.12% | 95 |
|
|
2025
Q1 | $17.7M | Buy |
289,748
+26,981
| +10% | +$1.57M | 0.09% | 89 |
|
|
2024
Q4 | $14.9M | Sell |
262,767
-41,337
| -14% | -$2.31M | 0.07% | 119 |
|
|
2024
Q3 | $15.7M | Sell |
304,104
-84,810
| -22% | -$3.98M | 0.08% | 115 |
|
|
2024
Q2 | $16.2M | Buy |
388,914
+16,096
| +4% | +$720K | 0.11% | 100 |
|
|
2024
Q1 | $20.2M | Buy |
372,818
+115,189
| +45% | +$5.87M | 0.15% | 72 |
|
|
2023
Q4 | $13.2M | Buy |
257,629
+40,810
| +19% | +$2.14M | 0.13% | 87 |
|
|
2023
Q3 | $12.6M | Sell |
216,819
-3,977
| -2% | -$244K | 0.14% | 85 |
|
|
2023
Q2 | $14.1M | Sell |
220,796
-23,654
| -10% | -$1.59M | 0.17% | 79 |
|
|
2023
Q1 | $16.9M | Sell |
244,450
-8,240
| -3% | -$581K | 0.2% | 65 |
|
|
2022
Q4 | $18.2M | Buy |
252,690
+50,249
| +25% | +$3.79M | 0.23% | 62 |
|
|
2022
Q3 | $14.4M | Buy |
202,441
+61,266
| +43% | +$4.44M | 0.23% | 56 |
|
|
2022
Q2 | $10.9M | Buy |
141,175
+37,707
| +36% | +$2.87M | 0.2% | 79 |
|
|
2022
Q1 | $7.56M | Buy |
103,468
+52,339
| +102% | +$3.51M | 0.11% | 107 |
|
|
2021
Q4 | $3.19M | Buy |
51,129
+40,390
| +376% | +$2.37M | 0.04% | 191 |
|
|
2021
Q3 | $635K | Buy |
+10,739
| New | +$707K | 0.01% | 373 |
|
|
2020
Q4 | – | Sell |
-11,969
| Closed | -$722K | – | 610 |
|
|
2020
Q3 | $722K | Buy |
11,969
+2,708
| +29% | +$163K | ﹤0.01% | 465 |
|
|
2020
Q2 | $544K | Sell |
9,261
-2,106
| -19% | -$126K | ﹤0.01% | 482 |
|
|
2020
Q1 | $634K | Sell |
11,367
-30,531
| -73% | -$1.87M | ﹤0.01% | 430 |
|
|
2019
Q4 | $2.69M | Sell |
41,898
-3,914,386
| -99% | -$224M | 0.01% | 259 |
|
|
2019
Q3 | $202M | Buy |
3,956,284
+1,048,783
| +36% | +$49.3M | 0.59% | 44 |
|
|
2019
Q2 | $131M | Buy |
2,907,501
+2,367,644
| +439% | +$110M | 0.4% | 71 |
|
|
2019
Q1 | $25.8M | Buy |
539,857
+118,406
| +28% | +$5.9M | 0.09% | 183 |
|
|
2018
Q4 | $21.9M | Buy |
421,451
+404,043
| +2,321% | +$21.7M | 0.09% | 180 |
|
|
2018
Q3 | $1.08M | Sell |
17,408
-843
| -5% | -$50K | ﹤0.01% | 472 |
|
|
2018
Q2 | $1.01M | Buy |
18,251
+2,600
| +17% | +$140K | ﹤0.01% | 498 |
|
|
2018
Q1 | $990K | Sell |
15,651
-2,768
| -15% | -$178K | ﹤0.01% | 496 |
|
|
2017
Q4 | $1.13M | Buy |
18,419
+618
| +3% | +$38.7K | ﹤0.01% | 498 |
|
|
2017
Q3 | $1.13M | Buy |
17,801
+1,200
| +7% | +$70.1K | ﹤0.01% | 476 |
|
|
2017
Q2 | $925K | Hold |
16,601
| – | – | ﹤0.01% | 505 |
|
|
2017
Q1 | $903K | Sell |
16,601
-607
| -4% | -$33.3K | ﹤0.01% | 485 |
|
|
2016
Q4 | $1.01M | Buy |
17,208
+928
| +6% | +$50.7K | ﹤0.01% | 459 |
|
|
2016
Q3 | $878K | Buy |
16,280
+2,159
| +15% | +$139K | ﹤0.01% | 456 |
|
|
2016
Q2 | $1.04M | Buy |
14,121
+5,120
| +57% | +$362K | ﹤0.01% | 448 |
|
|
2016
Q1 | $575K | Sell |
9,001
-1,715
| -16% | -$108K | ﹤0.01% | 474 |
|
|
2015
Q4 | $737K | Hold |
10,716
| – | – | ﹤0.01% | 448 |
|
|
2015
Q3 | $634K | Buy |
10,716
+732
| +7% | +$46.4K | ﹤0.01% | 420 |
|
|
2015
Q2 | $664K | Hold |
9,984
| – | – | ﹤0.01% | 427 |
|
|
2015
Q1 | $644K | Hold |
9,984
| – | – | ﹤0.01% | 439 |
|
|
2014
Q4 | $589K | Sell |
9,984
-414
| -4% | -$23.3K | ﹤0.01% | 417 |
|
|
2014
Q3 | $532K | Hold |
10,398
| – | – | ﹤0.01% | 427 |
|
|
2014
Q2 | $504K | Hold |
10,398
| – | – | ﹤0.01% | 419 |
|
|
2014
Q1 | $540K | Hold |
10,398
| – | – | ﹤0.01% | 410 |
|
|
2013
Q4 | $553K | Sell |
10,398
-295,852
| -97% | -$15.1M | ﹤0.01% | 416 |
|
|
2013
Q3 | $14.2M | Buy |
306,250
+100,100
| +49% | +$4.39M | 0.07% | 211 |
|
|
2013
Q2 | $9.21M | Buy |
+206,150
| New | +$8.95M | 0.05% | 212 |
|
Other funds holding BMY
VCM
VPM
Prudential plc's BMY Position: Q1 2026 in Review
Prudential plc reduced its Bristol-Myers Squibb (BMY) stake by 26% in Q1 2026, selling an estimated $5.23M and leaving 256,041 shares worth $15.5M. The position accounts for 0.09% of the portfolio, ranked #142.
Prudential plc first reported a position in BMY in Q2 2013 and has held it in 49 quarters since. The position peaked at $202M in Q3 2019. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Prudential plc held 256,041 shares of Bristol-Myers Squibb worth $15.5M as of Q1 2026.
- Prudential plc sold 89,663 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.23M.
- Bristol-Myers Squibb made up 0.09% of Prudential plc's portfolio in Q1 2026, its #142 holding.
- Prudential plc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 49 quarters since.
- Prudential plc's Bristol-Myers Squibb position peaked at $202M in Q3 2019.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.